May 2024
Private Healthcare Devices Company
Exclusive Financial Advisor to the Company on its Balance Sheet Recapitalization
Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)